SLC19A1 and Miyoshi myopathy: To determine the correlation of SLC19A1 expression with clinical features in MM patients, we classified the patients into a low SLC19A1 expression group (SLC19A1low, n = 9) and a high SLC19A1 expression group (SLC19A1high, n = 10) based on the median SLC19A1 expression level.